Chiyoda (6366) Investor presentation summary

Middle East execution

• Two major EPC projects continue in the Middle East; NFE engineering and procurement are in final stages, while construction progresses amid close monitoring of local conditions.

• Maritime transport constraints affected some work processes, prompting logistical measures; current-year financial impact is expected to be limited, with safety the top priority.

Business Plan 2025 progress

• Golden Pass LNG Train 1 construction and commissioning are complete, with first LNG production achieved; NFE construction has gradually resumed.

• A Business Development & Growth Transformation Division was established, and domestic project development advanced toward future EPC awards.

• CXO continues expanding domestic engineering operations; competency development for core personnel now emphasizes experience-based learning and assignments.

• The EPC pipeline spans oil and gas, CCS, hydrogen and ammonia, SAF and e-fuels, power, life sciences and metal resources.

Domestic growth and life sciences

• Domestic strategy combines stable maintenance and EPC earnings with growth in advanced materials, fine chemicals, decarbonization and new O&M areas.

• TOKYO OHKA KOGYO and Chiyoda signed an agreement to commercialize MPS, combining microfabrication and device expertise with cell culture and engineering capabilities.

• The MPS initiative aims to support next-generation drug discovery and extend life-sciences services from R&D assistance through implementation.